Jan Smidrkal
Senior Project Manager at Lonza Netherlands, former PharmaCell- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Credentials
-
Qualified Person
IPVZ (established by Ministry of Health)Sep, 2014- Nov, 2024 -
PRINCE - Project Management
-Nov, 2012- Nov, 2024
Experience
-
Lonza Netherlands, former PharmaCell
-
Netherlands
-
Pharmaceutical Manufacturing
-
100 - 200 Employee
-
Senior Project Manager
-
Jan 2020 - Present
- Leading multidisciplinary cross-functional team executing customer manufacturing project during (technology transfer and development, GMP manufacturing) - Cell & Gene Therapy - Leading multidisciplinary cross-functional team executing customer manufacturing project during (technology transfer and development, GMP manufacturing) - Cell & Gene Therapy
-
-
-
SOTIO Biotech
-
Czechia
-
Biotechnology Research
-
100 - 200 Employee
-
Global Project Manager
-
Sep 2017 - Sep 2019
Management preclinical and clinical Phase I drug development programs (Immuno-oncology) Management of 3 in-licensed programs (semi-virtual) heavily relying on CMO/CRO’s (small molecule, ADC, IL15 fusion protein) Management of crossfunctional teams, working groups and CMO’s/CRO’s focused on: • Non-clinical Development • Clinical Development • Clinical Operations • CMC Development/GMP manufacturing Managing Integrated Project Plan,scope, budget, change management of IL15 fusion protein which succesfully progressed from preclinical stage to Phase I Show less
-
-
-
Bohemian Biotech s.r.o.
-
Prague, The Capital, Czech Republic
-
CEO
-
Jan 2016 - Jul 2017
Industrial Pharmaceutical Biotechnology. Innovative and contract research organization. Industrial Pharmaceutical Biotechnology. Innovative and contract research organization.
-
-
-
Lonza
-
Switzerland
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Head of Project Management
-
Jul 2014 - Dec 2015
- Management of the CMO project scopes, timelines, resources and budgets- Leading multidisciplinary cross-functional teams executing customer manufacturing projects during their lifecycle - Management of the Sales&Operations plan of the Kourim site- Preparation of CMO contracts/amendments- Management of Technology Transfers to/from Lonza
-
-
Program Manager (Project Leader)
-
Jan 2011 - Jun 2014
- Leading multidisciplinary cross-functional teams executing customer manufacturing projects during their lifecycle (technology development or transfer, scale-up studies, process validation, commercial manufacturing) utilizing microbial fermentation or biotransformation, harvesting and product (proteins, oligomers, small molecules) purification- Managing the CMO project scopes, timelines, resources and budgets for customers ranging from small start-up companies to large pharma corporations - Managing execution of customer project activities necessary for:- - Robust process development/transfer and scale-up- - Successful process validation and submissions to regulatory authorities- - Maximizing value for Lonza and its customers (cost of goods, timeline, milestones)The products my projects were concerned with: 2 large peptides (API/GMP), 1 antibody fragment(API/GMP), 1 midsize antibiotic molecule (API/GMP),1 oligopeptide (34AA- veterinary API),1 small molecule (API/GMP), 3 oligosaccharides (food grade), ca. 5 small molecules (food, cosmetics ingredient, raw material)- Evaluation of new potential customer projects Show less
-
-
-
Teva Pharmaceuticals
-
Israel
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
QA Compliance Inspector
-
Aug 2008 - Jan 2011
- Compliance control of final drug product production adherence to regulatory filings (ANDAs) and cGMP - Leading a multidisciplinary team responsible for Annual Product Reviews of ca. 100 drug products - Responsible for daily quality agenda of products manufactured for US market - Compliance control of final drug product production adherence to regulatory filings (ANDAs) and cGMP - Leading a multidisciplinary team responsible for Annual Product Reviews of ca. 100 drug products - Responsible for daily quality agenda of products manufactured for US market
-
-
-
Avid Radiopharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
R&D Chemist
-
Jun 2007 - Jun 2008
- Designed, synthesized and characterized potential PET and SPECT imaging agents precursors for early detection of Alzheimer disease using organic synthesis - Developed methods for characterization and labelling - Prepared technical reports for INDAs and Avid IP claims - Designed, synthesized and characterized potential PET and SPECT imaging agents precursors for early detection of Alzheimer disease using organic synthesis - Developed methods for characterization and labelling - Prepared technical reports for INDAs and Avid IP claims
-
-
-
University of Pennsylvania
-
United States
-
Higher Education
-
700 & Above Employee
-
Graduate Research Assistant (Alfred Bader Graduate Fellowship)
-
2001 - 2007
PhD Thesis: “Self-Assembled Supramolecular Dendrimers as Porous Protein Mimics”. Advisor: Prof. Virgil Percec - Used a wide variety of synthetic, analytical and biophysical method to create body of work that was published in peer reviewed journals (Nature, J.Am.Chem.Soc., J.Org.Chem, Chem.Eur.J.). PhD Thesis: “Self-Assembled Supramolecular Dendrimers as Porous Protein Mimics”. Advisor: Prof. Virgil Percec - Used a wide variety of synthetic, analytical and biophysical method to create body of work that was published in peer reviewed journals (Nature, J.Am.Chem.Soc., J.Org.Chem, Chem.Eur.J.).
-
-
-
Takeda Pharmaceuticals (formerly Nycomed)
-
Switzerland
-
Pharmaceutical Manufacturing
-
500 - 600 Employee
-
R&D Chemist
-
Jan 1999 - Aug 1999
- Synthesized and characterized potential X-ray imaging agents - Participated on identifying relevant structural descriptors of hydrophilic iodinated substrates and implemented them into existing multivariate statistical model for design of x-ray contrast agents. - Synthesized and characterized potential X-ray imaging agents - Participated on identifying relevant structural descriptors of hydrophilic iodinated substrates and implemented them into existing multivariate statistical model for design of x-ray contrast agents.
-
-
Education
-
University of Pennsylvania
PhD., Chemistry -
University of Chemistry and Technology in Prague (UCT Prague)
MSc., Organic Chemistry